logo
Sign In
Farxiga vs. GlyxambiBerinert vs. CinryzeEmgality vs. QuliptaFarxiga vs. InvokanaFirazyr vs. SajazirGlyxambi vs. InvokanaInvokamet vs. SynjardyOpzelura vs. DupixentOrencia vs. RinvoqQulipta vs. VyeptiStelara vs. TremfyaSynjardy vs. VictozaTaltz vs. BimzelxVyepti vs. Nurtec ODTView all Comparisons
ADHD drugsAnxiety drugsAsthma drugsAtopic dermatitis drugsDepression drugsHeart failure drugsHypertension drugsLymphoma drugsOsteoarthritis drugsRheumatoid arthritis drugsRosacea drugsSchizophrenia drugsType 2 Diabetes drugsView all Indications
Bayer drugsAbbVie drugsAstraZeneca drugsEli Lilly and Company drugsGenetech drugsGlaxoSmithKline (GSK) drugsNovartis drugsPfizer drugsTakeda Pharmaceuticals drugsTeva Pharmaceuticals drugsAmgen drugsView all Manufacturers
Beta-Adrenergic BlockerAngiotensin Converting Enzyme InhibitorAngiotensin 2 Receptor BlockerCalcium Channel BlockerDiureticsHMG-CoA Reductase InhibitorProton Pump InhibitorSelective Serotonin Reuptake InhibitorNorepinephrine Reuptake InhibitorBenzodiazepinesOpioid AgonistsNonsteroidal Anti-inflammatory DrugsAntiepileptic AgentsAntipsychoticsAntihistaminesView all Classes
Wegovy®Ozempic®Mounjaro®Zepbound®Jardiance®Farxiga®Dupixent®Trulicity®Lyrica®Lipitor®Effexor®Concerta®Depakote®Trintellix®Rexulti®Rinvoq®Verzenio®Taltz®
For ProvidersRequest DemoJoin Research Panel
For BusinessHCP ChannelCommercial O/SEngageMarketplaceOneHubInsight
Tools & MorePrescribing InfoCoverageSavingsPatient ResourcesA-Z IndicationsCompare Drugs
CompanyAboutInsightsCareersContactSecurity
Legit Script Certified
Get the latest insights in your inbox
Follow us
Legit Script Certified
  • Terms and Conditions
  • Privacy Policy
  • © 2025 PrescriberPoint. All Rights Reserved.

    • Medications for Major Depressive Disorder

    FiltersReset Filters
    58 results

    • abilify mycite

      (ARIPIPRAZOLE)
      Otsuka America Pharmaceutical, Inc.
      Usage: ABILIFY MYCITE is indicated for treating adults with schizophrenia, bipolar I disorder (including both acute and maintenance phases), and as adjunctive therapy for Major Depressive Disorder. It features an Ingestible Event Marker (IEM) sensor to track medication ingestion.

    • aripiprazole

      (Aripiprazole)
      Ascend Laboratories, LLC
      Usage: Aripiprazole Oral Tablets are indicated for treating schizophrenia, acute manic and mixed episodes of Bipolar I Disorder, as an adjunctive treatment for Major Depressive Disorder, irritability associated with autistic disorder, and Tourette’s disorder.

    • aripiprazole

      (ARIPIPRAZOLE)
      Accord Healthcare, Inc.
      Usage: Aripiprazole tablets are indicated for the treatment of schizophrenia, acute manic and mixed episodes in bipolar I disorder, adjunctive treatment of major depressive disorder, irritability associated with autistic disorder, and Tourette's disorder.

    • aripiprazole

      (Aripiprazole)
      Amneal Pharmaceuticals LLC
      Usage: Aripiprazole oral solution is indicated for treating schizophrenia, acute manic and mixed episodes in Bipolar I Disorder, adjunctive treatment of major depressive disorder, irritability associated with autistic disorder, and Tourette’s disorder.

    • auvelity

      (dextromethorphan hydrobromide, bupropion hydrochloride)
      Axsome Therapeutics, Inc.
      Usage: AUVELITY is indicated for the treatment of major depressive disorder (MDD) in adults.

    • bupropion hydrochloride

      (Bupropion hydrochloride)
      Granules Pharmaceuticals Inc.
      Usage: Bupropion hydrochloride extended-release tablets (XL) are indicated for treating major depressive disorder (MDD) and preventing seasonal major depressive episodes in patients with seasonal affective disorder (SAD). Efficacy has been established in controlled clinical trials for both indications.

    • bupropion hydrochloride

      (bupropion hydrochloride)
      Alvogen Inc.
      Usage: Bupropion hydrochloride extended-release tablets (XL) are indicated for treating major depressive disorder (MDD) in adults. Efficacy was established in controlled trials for both acute treatment and maintenance therapy. Regular reevaluation of the drug's long-term usefulness is recommended for ongoing patient care.

    • bupropion hydrochloride

      (bupropion Hydrochloride)
      Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.
      Usage: Bupropion hydrochloride tablets are indicated for the treatment of major depressive disorder (MDD) according to DSM criteria, with efficacy established in several controlled trials involving adult subjects.

    • bupropion hydrochloride

      (BUPROPION HYDROCHLORIDE)
      Aurobindo Pharma Limited
      Usage: Bupropion hydrochloride tablets are indicated for the treatment of major depressive disorder (MDD) in adults, supported by clinical trials demonstrating efficacy in both inpatient and outpatient settings.

    • bupropion hydrochloride

      (Bupropion Hydrochloride)
      Major Pharmaceuticals
      Usage: Bupropion hydrochloride tablets are indicated for the treatment of major depressive disorder (MDD) in adults, as established in controlled clinical trials.